1. Cooper DS, Doherty GM, Haugen BR, Kloos RT, Lee SL, Mandel SJ, et al. Revised American Thyroid Association management guidelines for patients with thyroid nodules and differentiated thyroid cancer. Thyroid. 2009;19(11):1167–214.
2. Muratet JP, Daver A, Minier JF, Larra F. Influence of scanning doses of iodine-131 on subsequent first ablative treatment outcome in patients operated on for differentiated thyroid carcinoma. J Nucl Med. 1998;39(9):1546–50.
3. Muratet JP, Giraud P, Daver A, Minier JF, Gamelin E, Larra F. Predicting the efficacy of first iodine-131 treatment in differentiated thyroid carcinoma. J Nucl Med. 1997;38(9):1362–8.
4. Postgard P, Himmelman J, Lindencrona U, Bhogal N, Wiberg D, Berg G, et al. Stunning of iodide transport by I-131 irradiation in cultured thyroid epithelial cells. J Nucl Med. 2002;43(6):828–34.
5. Lassmann M, Luster M, Hanscheid H, Reiners C. Impact of I-131 diagnostic activities on the biokinetics of thyroid remnants. J Nucl Med. 2004;45(4):619–25.